Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,391 | 73,981 | 60,715 | 54,128 | 60,873 |
| Marketable Securities | 17,532 | 22,518 | 45,760 | 49,993 | 62,608 |
| Other current assets | 2,283 | 2,248 | 2,077 | 2,205 | 2,387 |
| TOTAL | $109,470 | $100,843 | $113,222 | $125,713 | $160,741 |
| Non-Current Assets | |||||
| PPE Net | 782 | 839 | 896 | 252 | 268 |
| Intangibles | 16,836 | 16,836 | 16,836 | 16,836 | 16,836 |
| Other Non-Current Assets | 13,651 | 14,267 | 14,804 | 15,137 | 43,282 |
| TOTAL | $31,269 | $31,942 | $32,536 | $32,225 | $60,386 |
| Total Assets | $140,739 | $132,785 | $145,758 | $157,938 | $221,127 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,515 | 37,668 | 26,299 | 26,241 | 26,184 |
| Accounts payable and accrued liabilities | 10,023 | 7,890 | 2,479 | 7,318 | 6,048 |
| Accrued Expenses | 7,683 | 7,334 | 7,965 | 9,675 | 9,432 |
| Other current liabilities | 40,269 | 1,941 | 3,757 | 2,051 | 1,442 |
| TOTAL | $79,361 | $55,793 | $41,511 | $46,217 | $44,023 |
| Non-Current Liabilities | |||||
| Long Term Debt | 93,139 | 91,614 | 109,934 | 108,074 | 116,525 |
| Other Non-Current Liabilities | 6,405 | 6,523 | 6,753 | 6,979 | 5,347 |
| TOTAL | $99,544 | $98,137 | $116,687 | $115,053 | $121,872 |
| Total Liabilities | $178,905 | $153,930 | $158,198 | $161,270 | $165,895 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,768 | 64,478 | 61,779 | 59,793 | 59,038 |
| Common Shares | 644 | 628 | 608 | 590 | 590 |
| Retained earnings | -616,004 | -585,220 | -557,770 | -537,624 | -474,180 |
| Other shareholders' equity | -26,026 | -26,341 | -27,909 | -26,328 | -25,042 |
| TOTAL | $-38,166 | $-21,145 | $-12,440 | $-3,332 | $55,232 |
| Total Liabilities And Equity | $140,739 | $132,785 | $145,758 | $157,938 | $221,127 |